| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/02/2023 | Mersana Therapeutics, Inc. | MRSN | Grant | Common Stock | 15.9k | $0.00 | $0 | | 10/02/2023 |
| 07/03/2023 | Mersana Therapeutics, Inc. | MRSN | Grant | Common Stock | 6.1k | $0.00 | $0 | | 07/03/2023 |
| 07/03/2023 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 1.5M | $0.00 | $0 | | 07/03/2023 |
| 06/15/2023 | ARDELYX, INC. | ARDX | Grant | Common Stock | 25.5k | $0.00 | $0 | | 06/15/2023 |
| 06/15/2023 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 49.2k | $3.92 | $193k | | 06/15/2023 |
| 06/08/2023 | Mersana Therapeutics, Inc. | MRSN | Grant | Common Stock | 14.5k | $0.00 | $0 | | 06/08/2023 |
| 06/08/2023 | Mersana Therapeutics, Inc. | MRSN | Grant | Stock Option (right to buy) | 18.4k | $8.64 | $158.6k | | 06/08/2023 |
| 04/03/2023 | Mersana Therapeutics, Inc. | MRSN | Grant | Common Stock | 4.9k | $0.00 | $0 | | 04/03/2023 |
| 11/17/2022 | ARDELYX, INC. | ARDX | Purchase | Common Stock | 567k | $1.76 | $1M | | 11/17/2022 |
| 08/12/2022 | Epizyme, Inc. | EPZM | Other | Common Stock, par value $0.0001 | 215.5k | $0.00 | $0 | | 08/12/2022 |
| 08/12/2022 | Epizyme, Inc. | EPZM | Disposition | Common Stock, par value $0.0001 | 9k | $0.00 | $0 | | 08/12/2022 |
| 08/12/2022 | Epizyme, Inc. | EPZM | Other | Common Stock, par value $0.0001 | 107k | $0.00 | $0 | See Note | 08/12/2022 |
| 07/01/2022 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 1M | $0.00 | $0 | | 07/01/2022 |
| 06/30/2022 | Epizyme, Inc. | EPZM | Grant | Common Stock, par value $0.0001 | 16.2k | $1.47 | $23.7k | | 06/30/2022 |
| 06/17/2022 | NOVAVAX INC | NVAX | Exercise | Restricted Stock Units | 700 | $0.00 | $0 | | 06/17/2022 |
| 06/15/2022 | ARDELYX, INC. | ARDX | Grant | Common Stock | 182.5k | $0.00 | $0 | | 06/15/2022 |
| 06/15/2022 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 100k | $0.55 | $54.8k | | 06/15/2022 |
| 06/10/2022 | NOVAVAX INC | NVAX | Grant | Stock Option (Right to Buy) | 4.6k | $40.62 | $186.9k | | 06/10/2022 |
| 06/10/2022 | NOVAVAX INC | NVAX | Grant | Restricted Stock Units | 3.1k | $0.00 | $0 | | 06/10/2022 |
| 06/09/2022 | Mersana Therapeutics, Inc. | MRSN | Grant | Stock Option (right to buy) | 45k | $3.62 | $162.9k | | 06/09/2022 |
| 06/02/2022 | Enliven Therapeutics, Inc. | IMRA | Grant | Stock Options (Right to Buy) | 8.5k | $1.07 | $9.1k | | 06/02/2022 |
| 05/17/2022 | Epizyme, Inc. | EPZM | Grant | Common Stock, par value $0.0001 | 9k | $0.00 | $0 | | 05/17/2022 |
| 05/17/2022 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 41k | $0.56 | $23k | | 05/17/2022 |
| 03/31/2022 | Epizyme, Inc. | EPZM | Grant | Common Stock, par value $0.0001 | 20.7k | $1.15 | $23.8k | | 03/31/2022 |
| 02/23/2022 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 35.3k | $1.46 | $51.5k | | 02/18/2022 |
| 02/22/2022 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 65.8k | $1.56 | $102.7k | | 02/18/2022 |
| 02/18/2022 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 50.4k | $1.30 | $65.5k | | 02/18/2022 |
| 02/17/2022 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 14.6k | $1.17 | $17.1k | | 02/15/2022 |
| 02/16/2022 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 11.8k | $1.20 | $14.1k | | 02/15/2022 |
| 02/15/2022 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 19.6k | $1.20 | $23.5k | | 02/15/2022 |
| 02/14/2022 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 8.5k | $1.18 | $10k | | 02/10/2022 |
| 02/11/2022 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 14.6k | $1.23 | $17.9k | | 02/10/2022 |
| 02/10/2022 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 8.8k | $1.29 | $11.3k | | 02/10/2022 |
| 01/03/2022 | Mersana Therapeutics, Inc. | MRSN | Grant | Stock Option (right to buy) | 18.5k | $6.44 | $119.3k | | 01/03/2022 |
| 12/31/2021 | Epizyme, Inc. | EPZM | Grant | Common Stock, par value $0.0001 | 9.5k | $2.50 | $23.8k | | 12/31/2021 |
|